{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:19:49Z","timestamp":1760188789855},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1996,2,1]],"date-time":"1996-02-01T00:00:00Z","timestamp":823132800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"published-print":{"date-parts":[[1996,2]]},"DOI":"10.1007\/bf02505047","type":"journal-article","created":{"date-parts":[[2006,10,11]],"date-time":"2006-10-11T12:25:42Z","timestamp":1160569542000},"page":"74-78","source":"Crossref","is-referenced-by-count":15,"title":["Elevated soluble CD23 levels in the sera from patients with localized scleroderma"],"prefix":"10.1007","volume":"288","author":[{"given":"Shinichi","family":"Sato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manabu","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanako","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hironobu","family":"Ihn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunihiko","family":"Tamaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiko","family":"Takehara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02505047_CR1","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/art.1780260506","volume":"26","author":"K Takehara","year":"1983","unstructured":"Takehara K, Moroi Y, Nakabayashi Y, Ishibashi Y (1983) Antinuclear antibodies in localized scleroderma. Arthritis Rheum 26:612\u2013616","journal-title":"Arthritis Rheum"},{"key":"BF02505047_CR2","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0190-9622(86)70217-X","volume":"15","author":"A Ruffatti","year":"1986","unstructured":"Ruffatti A, Peserico A, Glorioso S, Fiocco U, Rossi L, Gambari P, Todesco S (1986) Anticentromere antibody in localized scleroderma. J Am Acad Dermatol 15:637\u2013642","journal-title":"J Am Acad Dermatol"},{"key":"BF02505047_CR3","doi-asserted-by":"crossref","first-page":"849","DOI":"10.7326\/0003-4819-104-6-849","volume":"104","author":"V Falanga","year":"1986","unstructured":"Falanga V, Medsger TA Jr, Reichlin M, Rodnan GP (1986) Linear scleroderma: clinical spectrum, prognosis, and laboratory abnormalities. Ann Intern Med 104:849\u2013857","journal-title":"Ann Intern Med"},{"key":"BF02505047_CR4","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1001\/archderm.1987.01660270088021","volume":"123","author":"V Falanga","year":"1987","unstructured":"Falanga V, Medsger TA Jr, Reichlin M (1987) Antinuclear and anti-single-stranded DNA antibodies in morphea and generalized morphea. Arch Dermatol 123:350\u2013353","journal-title":"Arch Dermatol"},{"key":"BF02505047_CR5","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0190-9622(89)80310-X","volume":"21","author":"K Kikuchi","year":"1989","unstructured":"Kikuchi K, Takehara K, Ishibashi Y (1989) Antinuclear antibodies in localized sleroderma: unique staining in chromosome spreads. J Am Acad Dermatol 21:1301\u20131303","journal-title":"J Am Acad Dermatol"},{"key":"BF02505047_CR6","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/art.1780360815","volume":"36","author":"S Sato","year":"1993","unstructured":"Sato S, Ihn H, Soma Y, Igarashi A, Tamaki T, Kikuchi K, Ishibashi Y, Takehara K (1993) Antihistone antibodies in patients with localized scleroderma. Arthritis Rheum 36:1137\u20131141","journal-title":"Arthritis Rheum"},{"key":"BF02505047_CR7","first-page":"52","volume":"18","author":"JA Scarola","year":"1975","unstructured":"Scarola JA, Shulman LE (1975) Serologic abnormalities and their significance in localized scleroderma. Arthritis Rheum 18: 52","journal-title":"Arthritis Rheum"},{"key":"BF02505047_CR8","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1001\/archderm.121.3.345","volume":"121","author":"V Falanga","year":"1985","unstructured":"Falanga V, Medsger TA Jr, Reichlin M (1985) High titers of antibodies to single-stranded DNA in linear scleroderma. Arch Dermatol 121:345\u2013347","journal-title":"Arch Dermatol"},{"key":"BF02505047_CR9","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1001\/archderm.1990.01670340120025","volume":"126","author":"K Takehara","year":"1990","unstructured":"Takehara K, Kikuchi K, Soma Y, Igarashi A, Ishibashi Y (1990) Anti-single-stranded DNA antibody and muscle involvement in localized scleroderma. Arch Dermatol 126:1368\u20131369","journal-title":"Arch Dermatol"},{"key":"BF02505047_CR10","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1001\/archderm.1994.01690100057009","volume":"130","author":"S Sato","year":"1994","unstructured":"Sato S, Fujimoto M, Ihn H, Kikuchi K, Takehara K (1994) Antigen specificity of antihistone antibodies in localized scleroderma. Arch Dermatol 130:1273\u20131277","journal-title":"Arch Dermatol"},{"key":"BF02505047_CR11","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/BF01262331","volume":"287","author":"H Ihn","year":"1995","unstructured":"Ihn H, Sato S, Fujimoto M, Kikuchi K, Takehara K (1995) Demonstration of interleukin-2, interleukin-4 and interleukin-6 in sera from patients with localized scleroderma. Arch Dermatol Res 287:193\u2013197","journal-title":"Arch Dermatol Res"},{"key":"BF02505047_CR12","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0065-2776(08)60776-2","volume":"49","author":"G Delespesse","year":"1991","unstructured":"Delespesse G, Suter U, Mossalayi D, Bettler B, Sarfati M, Hofstetter H, Kilcherr E, Debre P, Dalloul A (1991) Expression, structure, and function of the CD23 antigen. Adv Immunol 49: 149\u2013191","journal-title":"Adv Immunol"},{"key":"BF02505047_CR13","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.4049\/jimmunol.138.8.2576","volume":"138","author":"K Yukawa","year":"1987","unstructured":"Yukawa K, Kikutani H, Owaki H, Yamasaki K, Yokota A, Nakamura H, Barsumian EL, Hardy RR, Suemura M, Kishimoto T (1987) A B cell-specific differentiation antigen, CD23, is a receptor for IgE (Fc\u03b5R) on lymphocytes. J Immunol 138:2576\u20132580","journal-title":"J Immunol"},{"key":"BF02505047_CR14","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1084\/jem.164.5.1455","volume":"164","author":"H Kikutani","year":"1986","unstructured":"Kikutani H, Suemura M, Owaki H, Nakamura H, Sato R, Yamasaki K, Barsumian EL, Hardy RR, Kishimoto T (1986) Fc\u03b5 receptor, a specific differentiation marker transiently expressed on mature B cells before isotype switching. J Exp Med 164:1455\u20131469","journal-title":"J Exp Med"},{"key":"BF02505047_CR15","first-page":"569","volume":"59","author":"M Sarfati","year":"1986","unstructured":"Sarfati M, Nutman T, Fonteyn C, Delespesse G (1986) Presence of antigenic determinants common to Fc IgE receptors on human macrophages, T and B lymphocytes and IgE-binding factors. Immunology 59:569\u2013575","journal-title":"Immunology"},{"key":"BF02505047_CR16","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/eji.1830160318","volume":"16","author":"M Joseph","year":"1986","unstructured":"Joseph M, Capron A, Ameisen JC, Capron M, Vorng H, Pancre V, Kusnierz JP, Auriault C (1986) The receptor for IgE on blood platelets. Eur J Immunol 16:306\u2013312","journal-title":"Eur J Immunol"},{"key":"BF02505047_CR17","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.4049\/jimmunol.126.6.2087","volume":"126","author":"M Capron","year":"1981","unstructured":"Capron M, Capron A, Dessaint JP, Torpier G, Johansson SGO, Prin L (1981) Fc receptors for IgE on human and rat eosinophils. J Immunol 126:2087\u20132092","journal-title":"J Immunol"},{"key":"BF02505047_CR18","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1084\/jem.172.3.693","volume":"172","author":"M Letellier","year":"1990","unstructured":"Letellier M, Nakajima T, Pulido-Cejudo G, Hofstetter H, Delespesse G (1990) Mechanism of formation of human IgE-binding factors (soluble CD23). III. Evidence for a receptor (Fc\u03b5RII)-associated proteolytic activity. J Exp Med 172:693\u2013700","journal-title":"J Exp Med"},{"key":"BF02505047_CR19","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0167-5699(89)90173-4","volume":"10","author":"G Delespesse","year":"1989","unstructured":"Delespesse G, Sarfati M, Hofstetter H (1989) Human IgE binding factors. Immunol Today 10:159\u2013164","journal-title":"Immunol Today"},{"key":"BF02505047_CR20","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0167-5699(89)90171-0","volume":"10","author":"J Gordon","year":"1989","unstructured":"Gordon J, Flores-Romo L, Cairns JA, Millsum MJ, Lane PJ, Johnson GD, MacLennan ICM (1989) CD23: a multi-functional receptor\/lymphokine? Immunol Today 10:153\u2013157","journal-title":"Immunol Today"},{"key":"BF02505047_CR21","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/eji.1830190106","volume":"19","author":"RJ Armitage","year":"1989","unstructured":"Armitage RJ, Goff LK, Beverley PCL (1989) Expression and functional role of CD23 on T cells. Eur J Immunol 19:31\u201335","journal-title":"Eur J Immunol"},{"key":"BF02505047_CR22","first-page":"547","volume":"67","author":"L Flores-Romo","year":"1989","unstructured":"Flores-Romo L, Cairns JA, Millsum MJ, Gordon J (1989) Soluble fragments of the low-affinity IgE receptor (CD23) inhibit the spontaneous migration of U937 monocytic cells: neutralization of MIF-activity by a CD23 antibody. Immunology 67: 547\u2013549","journal-title":"Immunology"},{"key":"BF02505047_CR23","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.4049\/jimmunol.141.7.2195","volume":"141","author":"M Sarfati","year":"1988","unstructured":"Sarfati M, Delespesse G (1988) Possible role of human lymphocyte receptor for IgE (CD23) or its soluble fragments in the in vitro synthesis of human IgE. J Immunol 141:2195\u20132199","journal-title":"J Immunol"},{"key":"BF02505047_CR24","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1084\/jem.171.3.959","volume":"171","author":"MD Mossalayi","year":"1990","unstructured":"Mossalayi MD, Lecron JC, Dalloul AH, Sarfati M, Bertho JM, Hofstetter H, Delespesse G, Debre P (1990) Soluble CD23 (Fc\u03b5RII) and interleukin 1 synergistically induce early human thymocyte maturation. J Exp Med 171:959\u2013964","journal-title":"J Exp Med"},{"key":"BF02505047_CR25","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1002\/eji.1830210819","volume":"21","author":"Y-J Liu","year":"1991","unstructured":"Liu Y-J, Mason DY, Johnson GD, Abbot S, Gregory CD, Hardie DL, Gordon J, MacLennan ICM (1991) Germinal center cells express bcl-2 protein after activation by signals which prevent their entry into apoptosis. Eur J Immunol 21:1905\u20131910","journal-title":"Eur J Immunol"},{"key":"BF02505047_CR26","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0190-9622(94)70217-9","volume":"31","author":"S Sato","year":"1994","unstructured":"Sato S, Fujimoto M, Ihn H, Kikuchi K, Takehara K (1994) Clinical characteristics associated with antihistone antibodies in patients with localized slceroderma. J Am Acad Dermatol 31: 567\u2013571","journal-title":"J Am Acad Dermatol"},{"key":"BF02505047_CR27","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/art.1780260506","volume":"26","author":"Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee","year":"1983","unstructured":"Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1983) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 26:612\u2013616","journal-title":"Arthritis Rheum"},{"key":"BF02505047_CR28","first-page":"202","volume":"15","author":"EC LeRoy","year":"1988","unstructured":"LeRoy EC, Black C, Fleischmajer P, et al (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15:202\u2013205","journal-title":"J Rheumatol"},{"key":"BF02505047_CR29","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/art.1780360215","volume":"36","author":"P Chomarat","year":"1993","unstructured":"Chomarat P, Briolay J, Banchereau J, Miossec P (1993) Increased production of soluble CD23 in rheumatoid arthritis, and its regulation by interleukin-4. Arthritis Rheum 36:234\u2013242","journal-title":"Arthritis Rheum"},{"key":"BF02505047_CR30","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1365-2249.1991.tb02937.x","volume":"86","author":"J Gordon","year":"1991","unstructured":"Gordon J (1991) CD23: novel disease marker with a split personality. Clin Exp Immunol 86:356\u2013359","journal-title":"Clin Exp Immunol"},{"key":"BF02505047_CR31","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1365-2249.1991.tb05682.x","volume":"85","author":"H Becker","year":"1991","unstructured":"Becker H, Potyka P, Weber C, Federlin K (1991) Detection of circulatig Fc\u03b5R2\/CD23+ monocytes in patients with rheumatic diseases. Clin Exp Immunol 85:61\u201365","journal-title":"Clin Exp Immunol"},{"key":"BF02505047_CR32","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/j.1365-2249.1992.tb06979.x","volume":"89","author":"A Bansal","year":"1992","unstructured":"Bansal A, Roberts T, Hay EM, Kay R, Pumphrey RSH, Wilson PB (1992) Soluble CD23 levels are elevated in the serum of patients with primary Sj\u00f6gren's syndrome and systemic lupus erythematosus. Clin Exp Immunol 89:452\u2013455","journal-title":"Clin Exp Immunol"},{"key":"BF02505047_CR33","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.1365-2249.1991.tb05720.x","volume":"85","author":"T Matsumoto","year":"1991","unstructured":"Matsumoto T, Miike T, Yamaguchi K, Murakami M, Kawabe T, Yodoji J (1991) Seru levels of soluble IL-2 receptor, IL-4 and IgE-binding factors in childhood allergic diseases. Clin Exp Immunol 85:288\u2013292","journal-title":"Clin Exp Immunol"},{"key":"BF02505047_CR34","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1365-2222.1990.tb02800.x","volume":"20","author":"Y Yanagihara","year":"1990","unstructured":"Yanagihara Y, Sarfati M, Marsh D, Nutman T, Delespesse G (1990) Serum levels of IgE-binding factor (soluble CD23) in diseases associated with elevated IgE. Clin Exp Allergy 20: 395\u2013401","journal-title":"Clin Exp Allergy"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02505047.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02505047\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02505047","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T08:53:46Z","timestamp":1683622426000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02505047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,2]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1996,2]]}},"alternative-id":["BF02505047"],"URL":"https:\/\/doi.org\/10.1007\/bf02505047","relation":{},"ISSN":["0340-3696","1432-069X"],"issn-type":[{"type":"print","value":"0340-3696"},{"type":"electronic","value":"1432-069X"}],"subject":[],"published":{"date-parts":[[1996,2]]}}}